Header Logo

Connection

David Bennett to Piperazines

Back to Details
This is a "connection" page, showing publications David Bennett has written about Piperazines.
David Bennett
Connection Strength
0.018
Piperazines
  1. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther. 1987 Mar; 240(3):737-46.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.